• condoebg1

      Missed TCT?

      See what you missed
      with TCTmd Gold

    • condoebg1

      See You in San Francisco

      October 12-16, 2015

TCT 2014

Sep. 13-17, 2014

Washington, DC

In Partnership with the ACC

 

Late-breaking clinical trials are typically first-time international or US presentations of the primary endpoint or important secondary endpoint results of prospective, randomized clinical trials or presentations of large-scale, impactful single-center or multicenter registries.

A first-report investigation is a smaller randomized trial, novel science, or early-human investigation.

Saturday, September 13, 2014

Main Arena

Main Arena I, Saturday, Sept. 13

8:00 am - 2:00 pm
Room: Level 3, Ballroom

This session is CME/CNE accredited.

Plenary Session V: Late-Breaking Clinical Trials #1

11:00 am - 12:00 pm

11:00 am

PARTNER I: Five-Year Results From a Prospective, Randomized Trial of Transcatheter Aortic Valve Replacement with a Balloon-Expandable Device Versus Conservative Care in Extremely High-Risk Patients with Aortic Stenosis

11:12 am

LBCT #1 - Discussion

11:24 am

US CoreValve High Risk Trial: Cost-Effectiveness Analysis From a Prospective, Randomized Trial of Transcatheter Aortic Valve Replacement with a Self-Expanding Device Versus Surgical Aortic Valve Replacement in High-Risk Patients with Aortic Stenosis

11:34 am

LBCT #2 - Discussion

11:42 am

CLEAN-TAVI: A Prospective, Randomized Trial of Cerebral Embolic Protection in High-Risk Patients with Aortic Stenosis Undergoing Transcatheter Aortic Valve Replacement

11:52 am

LBCT #3 - Discussion

Plenary Session VI: First Reports #1

12:00 pm - 12:30 pm

12:00 pm

The CoreValve US Pivotal Trial: Two-Year Results with a Self-Expanding Bioprosthesis in Extremely High-Risk Patients with Aortic Stenosis

12:10 pm

First Report #1 - Discussion

12:15 pm

ISAR-CLOSURE: A Prospective, Randomized Trial of Two Vascular Closure Devices Versus Manual Compression After Femoral Artery Access

12:25 pm

First Report #2 - Discussion

Sunday, September 14, 2014

Main Arena

Main Arena II, Sunday, Sept. 14

8:00 am - 2:00 pm
Room: Level 3, Ballroom

This session is CME/CNE accredited.

Plenary Session XII: Late-Breaking Clinical Trials #2

11:00 am - 12:00 pm

11:00 am

ABSORB II: A Prospective, Randomized Trial of an Everolimus-Eluting Bioresorbable Scaffold Versus an Everolimus-Eluting Metallic Stent in Patients with Coronary Artery Disease

11:12 am

LBCT #1 - Discussion

11:24 am

DKCRUSH-VI: A Prospective, Randomized Trial of FFR-Guided Versus Angiography-Guided Provisional T-Stenting in Patients with True Coronary Bifurcation Lesions

11:34 am

LBCT #2 - Discussion

11:42 am

RIBS IV: A Prospective, Randomized Trial of Paclitaxel-Eluting Balloons Versus Everolimus-Eluting Stents in Patients with Coronary In-Stent Restenosis of Drug-Eluting Stents

11:52 am

LBCT #3 - Discussion

Plenary Session XIII: First Reports #2

12:00 pm - 12:30 pm

12:00 pm

IVUS-CTO: A Prospective, Randomized Trial of Intravascular Ultrasound-Guided Versus Angiography-Guided Drug-Eluting Stent Intervention in Coronary Chronic Total Occlusions

12:10 pm

First Report #1 - Discussion

12:15 pm

OCT STEMI: A Prospective, Randomized Trial of Optical Coherence Tomography Guidance During Primary Percutaneous Coronary Intervention in Acute Myocardial Infarction

12:25 pm

First Report #2 - Discussion

Monday, September 15, 2014

Main Arena

Main Arena III, Monday, Sept. 15

8:00 am - 2:16 pm
Room: Level 3, Ballroom

This session is CME/CNE accredited.

Plenary Session XIX: Late-Breaking Clinical Trials #3

11:10 am - 12:06 pm

11:10 am

BRIGHT: A Prospective, Randomized Trial of Bivalirudin Monotherapy Versus Heparin Monotherapy Versus Heparin Plus Tirofiban in Patients with Acute Myocardial Infarction Undergoing Coronary Intervention

11:22 am

LBCT #1 - Discussion

11:30 am

ISAR-TRIPLE: A Prospective, Randomized Trial of Six Weeks Versus Six Months of Clopidogrel in Patients Treated with Concomitant Aspirin and Oral Anticoagulant Therapy Following Coronary Drug-Eluting Stent Implantation

11:40 am

LBCT #2 - Discussion

11:48 am

SECURITY: A Prospective, Randomized Trial of Six Months Versus 12 Months of Dual Antiplatelet Therapy Following Coronary Drug-Eluting Stent Implantation

11:58 am

LBCT #3 - Discussion

Plenary Session XX: First Reports #3

12:06 pm - 12:36 pm

12:06 pm

TRANSLATE-ACS: A Large-Scale Registry Comparing Patterns of Use and One-Year Outcomes with Prasugrel Versus Clopidogrel in Patients with Acute Myocardial Infarction Undergoing Percutaneous Coronary Intervention

12:16 pm

First Report #1 - Discussion

12:21 pm

VELOCITY: A Prospective, Randomized Trial of Peritoneal Hypothermia in Patients with Acute ST-Segment Elevation Myocardial Infarction Undergoing Percutaneous Coronary Intervention

12:31 pm

First Report #2 - Discussion

Tuesday, September 16, 2014

Main Arena

Main Arena IV, Tuesday, Sept. 16

8:00 am - 2:00 pm
Room: Level 3, Ballroom

This session is CME/CNE accredited.

Plenary Session XXVI: Late-Breaking Clinical Trials #4

11:00 am - 12:00 pm

11:00 am

PRIMA: A Prospective, Randomized Trial of PFO Closure in Patients with Refractory Migraine with Aura

11:12 am

LBCT #1 - Discussion

11:24 am

Symplicity Flex: A Prospective, Randomized, Sham-Controlled Trial of Renal Sympathetic Denervation in Patients with Mild Refractory Hypertension

11:34 am

LBCT #2 - Discussion

11:42 am

EXCITE ISR: A Prospective, Randomized Trial of Excimer Laser Atherectomy Versus Balloon Angioplasty for Treatment of Femoropopliteal In-Stent Restenosis

11:52 am

LBCT #3 - Discussion

Plenary Session XXVII: First Reports #4

12:00 pm - 12:30 pm

12:00 pm

I-LOVE-IT 2: A Prospective, Randomized Trial of a Biodegradable Polymer, Cobalt Chromium, Sirolimus-Eluting Stent Versus a Durable Polymer, Cobalt Chromium, Sirolimus-Eluting Stent in Patients with Coronary Artery Disease

12:10 pm

First Report #1 - Discussion

12:15 pm

EVERBIO II: A Prospective, Randomized Trial of an Everolimus-Eluting Bioresorbable Scaffold Versus Everolimus-Eluting and Biolimus-Eluting Metallic Stents in Patients with Coronary Artery Disease

12:25 pm

First Report #2 - Discussion